Selected research
Market Structure
Global Blonanserin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Blonanserin Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Blonanserin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Blonanserin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Blonanserin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Blonanserin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Blonanserin Tablets include Intas, Lifecare Neuro Products, Recipharm, Sumitomo Pharma, Taj Life Sciences, LIVZON PHARMACEUTICAL, Shijiazhuang No.4 Pharmaceutical and Xiangzhong Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Blonanserin Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Blonanserin Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Blonanserin Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blonanserin Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Blonanserin Tablets Segment by Company
Intas
Lifecare Neuro Products
Recipharm
Sumitomo Pharma
Taj Life Sciences
LIVZON PHARMACEUTICAL
Shijiazhuang No.4 Pharmaceutical
Xiangzhong Pharmaceutical
Blonanserin Tablets Segment by Type
4mg
8mg
Blonanserin Tablets Segment by Application
Adults
Children
Blonanserin Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blonanserin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blonanserin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blonanserin Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Blonanserin Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blonanserin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blonanserin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Blonanserin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 4mg
- 8mg
Applications
- Adults
- Children
Companies covered
- Intas
- Lifecare Neuro Products
- Recipharm
- Sumitomo Pharma
- Taj Life Sciences
- LIVZON PHARMACEUTICAL
- Shijiazhuang No.4 Pharmaceutical
- Xiangzhong Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Blonanserin Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Blonanserin Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Blonanserin Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Blonanserin Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Blonanserin Tablets Market Dynamics
- 2.1 Blonanserin Tablets Industry Trends
- 2.2 Blonanserin Tablets Industry Drivers
- 2.3 Blonanserin Tablets Industry Opportunities and Challenges
- 2.4 Blonanserin Tablets Industry Restraints
3 Blonanserin Tablets Market by Manufacturers
- 3.1 Global Blonanserin Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Blonanserin Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Blonanserin Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Blonanserin Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Blonanserin Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Blonanserin Tablets Manufacturers, Product Type & Application
- 3.7 Global Blonanserin Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Blonanserin Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Blonanserin Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Blonanserin Tablets Tier 1, Tier 2, and Tier 3
4 Blonanserin Tablets Market by Type
- 4.1 Blonanserin Tablets Type Introduction
- 4.1.1 4mg
- 4.1.2 8mg
- 4.2 Global Blonanserin Tablets Sales by Type
- 4.2.1 Global Blonanserin Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Blonanserin Tablets Sales by Type (2021-2032)
- 4.2.3 Global Blonanserin Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Blonanserin Tablets Revenue by Type
- 4.3.1 Global Blonanserin Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Blonanserin Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Blonanserin Tablets Revenue Market Share by Type (2021-2032)
5 Blonanserin Tablets Market by Application
- 5.1 Blonanserin Tablets Application Introduction
- 5.1.1 Adults
- 5.1.2 Children
- 5.2 Global Blonanserin Tablets Sales by Application
- 5.2.1 Global Blonanserin Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Blonanserin Tablets Sales by Application (2021-2032)
- 5.2.3 Global Blonanserin Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Blonanserin Tablets Revenue by Application
- 5.3.1 Global Blonanserin Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Blonanserin Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Blonanserin Tablets Revenue Market Share by Application (2021-2032)
6 Global Blonanserin Tablets Sales by Region
- 6.1 Global Blonanserin Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Blonanserin Tablets Sales by Region (2021-2032)
- 6.2.1 Global Blonanserin Tablets Sales by Region (2021-2026)
- 6.2.2 Global Blonanserin Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Blonanserin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Blonanserin Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Blonanserin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Blonanserin Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Blonanserin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Blonanserin Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Blonanserin Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Blonanserin Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Blonanserin Tablets Revenue by Region
- 7.1 Global Blonanserin Tablets Revenue by Region
- 7.1.1 Global Blonanserin Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Blonanserin Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Blonanserin Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Blonanserin Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Blonanserin Tablets Revenue (2021-2032)
- 7.2.2 North America Blonanserin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Blonanserin Tablets Revenue (2021-2032)
- 7.3.2 Europe Blonanserin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Blonanserin Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Blonanserin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Blonanserin Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Blonanserin Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Intas
- 8.1.1 Intas Company Information
- 8.1.2 Intas Business Overview
- 8.1.3 Intas Blonanserin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Intas Blonanserin Tablets Product Portfolio
- 8.1.5 Intas Recent Developments
- 8.2 Lifecare Neuro Products
- 8.2.1 Lifecare Neuro Products Company Information
- 8.2.2 Lifecare Neuro Products Business Overview
- 8.2.3 Lifecare Neuro Products Blonanserin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Lifecare Neuro Products Blonanserin Tablets Product Portfolio
- 8.2.5 Lifecare Neuro Products Recent Developments
- 8.3 Recipharm
- 8.3.1 Recipharm Company Information
- 8.3.2 Recipharm Business Overview
- 8.3.3 Recipharm Blonanserin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Recipharm Blonanserin Tablets Product Portfolio
- 8.3.5 Recipharm Recent Developments
- 8.4 Sumitomo Pharma
- 8.4.1 Sumitomo Pharma Company Information
- 8.4.2 Sumitomo Pharma Business Overview
- 8.4.3 Sumitomo Pharma Blonanserin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sumitomo Pharma Blonanserin Tablets Product Portfolio
- 8.4.5 Sumitomo Pharma Recent Developments
- 8.5 Taj Life Sciences
- 8.5.1 Taj Life Sciences Company Information
- 8.5.2 Taj Life Sciences Business Overview
- 8.5.3 Taj Life Sciences Blonanserin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Taj Life Sciences Blonanserin Tablets Product Portfolio
- 8.5.5 Taj Life Sciences Recent Developments
- 8.6 LIVZON PHARMACEUTICAL
- 8.6.1 LIVZON PHARMACEUTICAL Company Information
- 8.6.2 LIVZON PHARMACEUTICAL Business Overview
- 8.6.3 LIVZON PHARMACEUTICAL Blonanserin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 LIVZON PHARMACEUTICAL Blonanserin Tablets Product Portfolio
- 8.6.5 LIVZON PHARMACEUTICAL Recent Developments
- 8.7 Shijiazhuang No.4 Pharmaceutical
- 8.7.1 Shijiazhuang No.4 Pharmaceutical Company Information
- 8.7.2 Shijiazhuang No.4 Pharmaceutical Business Overview
- 8.7.3 Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Product Portfolio
- 8.7.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
- 8.8 Xiangzhong Pharmaceutical
- 8.8.1 Xiangzhong Pharmaceutical Company Information
- 8.8.2 Xiangzhong Pharmaceutical Business Overview
- 8.8.3 Xiangzhong Pharmaceutical Blonanserin Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Xiangzhong Pharmaceutical Blonanserin Tablets Product Portfolio
- 8.8.5 Xiangzhong Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Blonanserin Tablets Value Chain Analysis
- 9.1.1 Blonanserin Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Blonanserin Tablets Production Mode & Process
- 9.2 Blonanserin Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Blonanserin Tablets Distributors
- 9.2.3 Blonanserin Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst